News From PTI

More from PTI

• Venus Remedies gets Ukrainian GMP renewal certification

  Venus Remedies already has a robust presence in 32 PIC/S countries, including South Africa, Thailand, Malaysia, Saudi Arabia, and Australia, with plans for continued expansion, it said.

  

• Sun Pharma to invest $25 mn in Pharmazz Inc; raises stake to 22.7 pc

  Pharmazz Inc is a biopharmaceutical company, developing two leading drug candidates, Sovateltide for treatment of acute cerebral ischemic stroke and Centhaquine for treatment of hypovolemic shock.

  

• Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue rises to Rs 161 cr

  The Ahmedabad-based company in a statement said that it focuses on expanding its global footprint by registering new products for export and also building a portfolio in lifestyle and chronic segments.

  

• Aman Mehta appointed Managing Director of Torrent Pharma

  In his role as Executive Director at Torrent Pharma, Aman was primarily involved in the India business, Torrent's largest revenue contributor, according to his profile provided by the company.

  

• Dr Reddy's gets 2 observations from USFDA for New York API plant

  The US Food and Drug Administration completed a Good Manufacturing Practice (GMP) inspection at the company's API (active pharmaceutical ingredients) Middleburgh facility in New York, Dr Reddy's said in a regulatory filing

  

• Singapore may escape tariff on pharma exports to US, says Deputy Prime Minister Gan

  Pharmaceutical goods are currently exempt from the baseline tariff rate of 10 per cent on imports to the US, which kicked in on April 5. But the US began looking into imposing duties on pharmaceuticals and semiconductors in mid-April.

  

• Fake drugs worth over Rs 30 crore seized in UP in PAST one year: FSDA

  In Lucknow, several important raids were carried out with the help of the Special Task Force (STF), targeting counterfeit drugs and oxytocin.

  

• US govt order unlikely to impact on Indian pharma players, says Cipla

  The order calls on the health department to broker new price tags for drugs. If a deal is not reached, a new rule will kick in that will tie the price of what the US pays for medications to lower prices paid by other countries.

  

• India has not accepted 'data exclusivity' demand by UK to protect generic drug firms

  By gaining exclusive rights over this data, innovator companies can prevent their competitors from obtaining a marketing licence for low-cost versions during the tenure of this exclusivity.

  

• Trump's drug price cut plan may trigger global repricing, pressure on India: GTRI

  As global pharmaceutical firms turn to free trade agreements (FTAs) to extract WTO-plus commitments, India must hold the line on its patent regime, one that enables affordable access, prevents monopolistic extensions, and safeguards public health.

  

• FDC recalls over 60,000 bottles of ophthalmic solution in US

  The company is recalling the affected lot due to "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle," the USFDA said.